Friday, January 27, 2017

BRIEF-AbbVie says continues to see good Humira growth in international markets despite indirect biosimilar competition - Conf Call

* AbbVie says continues to see good Humira growth in

international markets despite indirect biosimilar competition:

Conf Call

Read more

No comments:

Post a Comment